Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
03/31/2025 | Q1 | $13.7M | -- | -- | -$0.23 | -- |
03/04/2025 | Q4 | $15M | -- | -- | -$0.18 | -- |
11/07/2024 | Q3 | $11.5M | $13.5M | -$0.13 | -$0.30 | $0.17 |
08/08/2024 | Q2 | $12.2M | $12.6M | -$0.79 | -$0.30 | -$0.50 |
05/09/2024 | Q1 | $10.6M | $10.6M | -$0.19 | -$0.29 | $0.10 |
03/04/2024 | Q4 | $12M | $12.1M | -$0.35 | -$0.22 | -$0.13 |
11/09/2023 | Q3 | -- | -- | -$0.23 | -$0.34 | $0.11 |
08/09/2023 | Q2 | -- | -- | -$0.81 | -$0.35 | -$0.46 |
05/15/2023 | Q1 | -- | -- | -$0.40 | -$0.27 | -$0.13 |
03/16/2023 | Q4 | -- | -- | -$0.24 | -$0.25 | $0.01 |
11/09/2022 | Q3 | -- | -- | -$0.39 | -$0.62 | $0.23 |
08/08/2022 | Q2 | -- | -- | -$0.67 | -- | -- |
05/09/2022 | Q1 | -- | -- | -$0.67 | -- | -- |
03/03/2022 | Q4 | -- | -- | -$0.41 | -- | -- |
11/08/2021 | Q3 | -- | -- | -$0.65 | -- | -- |
08/05/2021 | Q2 | -- | -- | -$0.47 | -- | -- |
05/05/2021 | Q1 | -- | -- | -$0.56 | -- | -- |
03/10/2021 | Q4 | -- | -- | -$0.78 | -- | -- |
11/09/2020 | Q3 | -- | -- | -$0.64 | -- | -- |
03/31/2020 | Q1 | -- | -- | -$0.35 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.23 | -- | -- |
09/30/2019 | Q3 | -- | -- | -$0.55 | -- | -- |
LENSAR reported $13.5M worth of top line sales in its most recent quarter.
LENSAR announced earnings per share of -$0.13 which represents a beat of analyst forecast a -$0.30 per share.
LENSAR reported $6.3M that represents $0.54 per share over the last quarter.
LENSAR's earnings are forecast to decrease from -$1.31 per share to -$1.29 per share next year representing a decrease of -1.91%.
LENSAR's next earnings date is March 4, 2025.
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.